Fernandez‐Pereira 2006.

Methods	Type of study: parallel RCT Type of publication: abstract Source of funding: not reported Country of origin: Buenos Aires, Argentina Number of centres: 1 Dates of trial enrolment: 02/04 to 01/06 Length of follow‐up: 4 months Number (N) of participants randomised to each arm: not reported Number (N) of participants analysed (primary outcome) in each arm: not reported
Participants	Population: AMI Age mean (SD) each arm: not reported Sex % male in each arm: not reported Number of diseased vessels: not reported Number of stunned hyperkinetic, etc segments: not reported Time from symptom onset to initial treatment: not reported Statistically significant baseline imbalances between the groups? BMSC group baseline LVEF significantly lower than control group (P value = 0.005)
Interventions	Intervention arm: BMSC Type of stem cells: bone marrow‐derived stem cells (mononuclear cells‐MNC) Summary of how stem cells were isolated and type and route of delivery: not reported Dose of stem cells: not reported Timing of stem cell procedure: not reported Comparator arm: no additional therapy (control)
Outcomes	Primary outcomes: LVEF Secondary outcomes: cardiac events (ventricular arrhythmias, restenoses) Outcome assessment points: baseline and 4 months Method(s): angiography
Notes	Total sample size is 30 ‐ BMSC/control group sample sizes not reported